Greater physical activity and higher androgen concentrations are independently associated with lower cardiometabolic risk in men

Clin Endocrinol (Oxf). 2017 Nov;87(5):466-474. doi: 10.1111/cen.13407. Epub 2017 Jul 28.

Abstract

Context: Male ageing is associated with lower circulating testosterone (T) and increased incidence of cardiovascular disease (CVD). Whether physical activity (PA) interacts with hormones to modify CVD risk is unclear.

Objective: We assessed whether PA and sex hormone concentrations were independently associated with measures of CVD risk.

Participants: A total of 1649 men.

Methods: Leisure, home, work and total PA were ascertained. At baseline, serum T, dihydrotestosterone (DHT) and oestradiol (E2) were assayed. Men were stratified into high PA+high hormone (H/H); low PA+high hormone (L/H); high PA+low hormone (H/L); and low PA+low hormone (L/L).

Results: Mean age was 49.8 years at outset with 415 CVD events and 127 CVD deaths occurring during 20-year follow-up. Men with higher PA and higher T or DHT had lower odds of metabolic syndrome (eg leisure H/H vs L/L odds ratio [OR] 0.17 P<.001 for T, 0.26 P<.001 for DHT). Men with higher PA and E2 had lower risk of metabolic syndrome (eg leisure PA H/H vs L/L OR 0.51, P=.001). Men with higher leisure, work or total PA and higher DHT had the lowest risk of CVD death (eg leisure H/H hazard ratio [HR] 0.55 vs L/L, P=.033). Men with lower leisure, home or work PA and higher E2 were at greater risk of CVD death (eg leisure L/H HR 1.60 vs L/L, P=.039).

Conclusions: Considering T, DHT and E2 in the context of PA better informs consideration of cardiovascular risk. A 2×2 factorial RCT assessing PA and androgens would illuminate the scope for preventing CVD in men.

Keywords: cardiovascular disease; metabolic syndrome; physical activity; testosterone.

MeSH terms

  • Androgens / blood*
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Dihydrotestosterone / blood
  • Estradiol / blood
  • Exercise / physiology*
  • Humans
  • Male
  • Middle Aged
  • Risk Assessment
  • Testosterone / blood

Substances

  • Androgens
  • Dihydrotestosterone
  • Testosterone
  • Estradiol